Improving the comparability of data across the Member States is
a central task of the EMCDDA. The EMCDDA develops and recommends
new methods and instruments in order to collect and analyse harmonised,
good quality data at European level. The EU Action Plan on Drugs
(2000-04) calls for Member States to provide reliable and comparable
information on five key epidemiological indicators according to
the EMCDDA's recommended technical tools and guidelines.
Please let us know the availability information on the following
EMCDDA five key indicators regarding the Roma community:
• prevalence and patterns of drug use among the general
population (population surveys)
• prevalence and patterns of problem drug use (statistical
prevalence/incidence estimates and surveys among drug users);
• drug-related infectious diseases (prevalence and incidence
rates of HIV, hepatitis B and C in injecting drug users);
• drug-related deaths and mortality of drug users (general
population mortality special registers statistics, and mortality
cohort studies among drug users);
• demand for drug treatment (statistics from drug treatment
centres on clients starting treatment).
For
further information on these indicators: http://www.emcdda.eu.int/?nnodeid=1365
